Aucentra is excited to be awarded a seed-start grant of $700k by the South Australian government’s research and innovation fund. This funding will be used to test Aucentra’s leading drug candidate Auceliciclib.

Auceliciclib, if successful in its clinical trials, will be a game-changing treatment of glioblastoma multiforme, which is the most aggressive type of brain cancer and the most difficult to treat.

The Minister for Innovation and Skills David Pisoni recognised Aucentra’s ground-breaking achievements; “I am incredibly proud of Professor Wang and her team at the University of South Australia for the amazing work they have accomplished”.

Auceliciclib is a CDK4 and 6 inhibitor with a high specificity which allows for prevention of cancer cell growth and proliferation with fewer side effects. Read the full article here: